Benoit destenaves
Head Senior Director, Oncology Translational Medicine Operations & Experimental Oncology AstraZeneca
Seminars
Monday 16th November 2026
Designing for Execution: Bridging Scientific Ambition & Operational Reality in Biomarker-Enabled Trials
4:15 pm
- What role should biomarker operations play in protocol design, and how should site feasibility, sample collection requirements, patient burden, and operational realities inform those decisions?
- How can translational, biomarker operations, clinical operations, laboratory, and CRO partners come together earlier to anticipate operational challenges and plan the end-to-end journey from sample collection through testing, analysis, and data delivery?
- What does successful execution look like, and how can operational metrics, technology, and lessons learned improve visibility, scalability, and delivery of biomarker strategies across studies?
Moderated by:
Tuesday 17th November 2026
Leveraging AI & Automation to Speed Up Biomarker Operations & Quality of Delivery
11:30 am
- Biomarker operations is highly manual and time consuming
- Implementing AI and automation to address bottlenecks in the end-to-end biosample flow
- Harnessing AI can significantly reduce manual tasks and the overall quality biomarker results
